Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Receivables - Other: 2017-2020

Historic Receivables - Other for Mimedx Group (MDXG) over the last 4 years, with Dec 2020 value amounting to $200,000.

  • Mimedx Group's Receivables - Other was N/A to $400,000 in Q2 2021 from the same period last year, while for Jun 2021 it was $400,000, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2020, which is 84.62% down from last year.
  • Per Mimedx Group's latest filing, its Receivables - Other stood at $200,000 for FY2020, which was down 84.62% from $1.3 million recorded in FY2019.
  • Mimedx Group's 5-year Receivables - Other high stood at $5.9 million for FY2017, and its period low was $200,000 during FY2020.
  • For the 3-year period, Mimedx Group's Receivables - Other averaged around $1.9 million, with its median value being $1.3 million (2019).
  • Data for Mimedx Group's Receivables - Other shows a maximum YoY crashed of 84.62% (in 2020) over the last 5 years.
  • Mimedx Group's Receivables - Other (Yearly) stood at $5.9 million in 2017, then decreased by 27.12% to $4.3 million in 2018, then slumped by 69.77% to $1.3 million in 2019, then plummeted by 84.62% to $200,000 in 2020.